Radiopharm Theranostics Ltd: Appendix 4E and Preliminary Final Report

19:53 ET · Announcements

Radiopharm Theranostics Raises Stake in Radiopharm Ventures to 75%

MT NewswiresAug 26 04:59 ET

Radiopharm Theranostics Appoints Chief Medical Officer; Shares Down 5%

MT NewswiresAug 19 21:14 ET

Lantheus Pays $2 Million to Radiopharm Theranostics Under Preclinical Assets Transfer and Development Agreement

MT NewswiresAug 4 23:51 ET

Radiopharm Theranostics Earns FDA Approval for Brain Metastasis Imaging Agent RAD 101

Small CapsJul 22 23:11 ET

Radiopharm Theranostics Doses First Patient in Phase One Lung Cancer Trial

MT NewswiresJul 11 03:12 ET